Literature DB >> 11936467

Apathetic Graves' disease and acquired hemophilia due to factor VIIIc antibody.

F Marongiu1, C Cauli, G Mameli, B Usai, S Mariotti.   

Abstract

Acquired hemophilia due to autoantibody to Factor VIII coagulant (Factor VIIIc) is a rare event which may be observed in patients with different autoimmune diseases. To our knowledge, this association has been reported only once in patients with autoimmune thyroid disease. Here we describe a patient presenting with a severe hemorrhagic disorder due to Factor VIIIc antibody in whom biochemical screening for thyroid diseases led to a diagnosis of hyperthyroid Graves' disease not associated to overt clinical features. This case underlines the importance of carrying out a complete screening for autoimmunity, including thyroid autoimmune disease, in all patients with apparently isolated serum Factor VIIIc inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936467     DOI: 10.1007/BF03343998

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Anticardiolipin antibodies in Grave's disease: relationship with thrombin activity in vivo.

Authors:  F Marongiu; M Conti; M L Murtas; G G Sorano; G Mameli; G Salis; A Mathieu; E Martino
Journal:  Thromb Res       Date:  1991-12-15       Impact factor: 3.944

Review 2.  The pathogenesis of Graves' disease.

Authors:  B McIver; J C Morris
Journal:  Endocrinol Metab Clin North Am       Date:  1998-03       Impact factor: 4.741

Review 3.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

Review 4.  Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis?

Authors:  P D Woolf
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

Review 5.  Iodine-induced hyperthyroidism: occurrence and epidemiology.

Authors:  J B Stanbury; A E Ermans; P Bourdoux; C Todd; E Oken; R Tonglet; G Vidor; L E Braverman; G Medeiros-Neto
Journal:  Thyroid       Date:  1998-01       Impact factor: 6.568

6.  Anti-cardiolipin antibodies in autoimmune thyroid diseases.

Authors:  A Paggi; D Caccavo; G M Ferri; M A Di Prima; A Amoroso; F Vaccaro; L Bonomo; A Afeltra
Journal:  Clin Endocrinol (Oxf)       Date:  1994-03       Impact factor: 3.478

Review 7.  Autoimmune thyroid disease: further developments in our understanding.

Authors:  A P Weetman; A M McGregor
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

8.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

Review 9.  The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases.

Authors:  M E Ludgate; G Vassart
Journal:  Baillieres Clin Endocrinol Metab       Date:  1995-01

Review 10.  Iodide-induced thyrotoxicosis.

Authors:  J E Fradkin; J Wolff
Journal:  Medicine (Baltimore)       Date:  1983-01       Impact factor: 1.889

View more
  4 in total

Review 1.  Thyroid-associated autoimmune coagulation disorders.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato; Pier Paolo Vescovi
Journal:  J Thromb Thrombolysis       Date:  2009-03-10       Impact factor: 2.300

Review 2.  Hemostasis and thyroid diseases revisited.

Authors:  M Franchini
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

Review 3.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 4.  Hemostasis in Overt and Subclinical Hyperthyroidism.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.